H1B Report
Side-by-side comparison

Deloitte Consulting LLP vs Prime Medicine Inc.

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Deloitte Consulting LLP
PARank #4FEIN 06-1454513
Entity B
Prime Medicine Inc.
MARank #FEIN 84-3097762

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricDeloitte Consulting LLPPrime Medicine Inc.
Total filings79,21264
Certified %98.22%85.94%
Denied %1.09%4.69%
Withdrawn %0.61%1.56%
Cert-withdrawn %0.07%7.81%
Rank#4
Active yearsFY2010–FY2026FY2013–FY2024
Worksite statePAMA

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Outcomes — Prime Medicine Inc.

DOL case-status mix.

Outcome breakdown: Certified 85.9%, Cert-withdrawn 7.8%, Withdrawn 1.6%, Denied 4.7%
Outcome breakdown
OutcomeShare
Certified85.9%
Cert-withdrawn7.8%
Withdrawn1.6%
Denied4.7%
Certified85.9%
Cert-withdrawn7.8%
Withdrawn1.6%
Denied4.7%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,357
FY20113,610
FY20124,667
FY20136,024
FY20146,873
FY20157,505
FY20167,371
FY20177,040
FY201816,029
FY20197,724
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20261,792
Prime Medicine Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20100
FY20110
FY20120
FY20132
FY201416
FY20152
FY20163
FY201721
FY20182
FY20195
FY20200
FY20210
FY20221
FY20236
FY20246
FY20250
FY20260

Top 5 occupations — Deloitte Consulting LLP

Top 5 occupations — Prime Medicine Inc.

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.